0001231919-25-000186.txt : 20250911 0001231919-25-000186.hdr.sgml : 20250911 20250910183550 ACCESSION NUMBER: 0001231919-25-000186 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250911 DATE AS OF CHANGE: 20250910 EFFECTIVENESS DATE: 20250911 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Enlaza Therapeutics, Inc. CENTRAL INDEX KEY: 0001852950 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-557255 FILM NUMBER: 251306841 BUSINESS ADDRESS: STREET 1: 11099 NORTH TORREY PINES ROAD, STE. 280 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-348-2180 MAIL ADDRESS: STREET 1: 11099 NORTH TORREY PINES ROAD, STE. 280 CITY: LA JOLLA STATE: CA ZIP: 92037 D 1 primary_doc.xml X0708 D LIVE 0001852950 Enlaza Therapeutics, Inc. 11099 NORTH TORREY PINES ROAD, STE. 280 LA JOLLA CA CALIFORNIA 92037 858-348-2180 DELAWARE None None Corporation true 2020 Sergio Duron c/o Enlaza Therapeutics, Inc. 11099 North Torrey Pines Road, Ste 280 La Jolla CA CALIFORNIA 92037 Executive Officer Director Sanford Madigan c/o Enlaza Therapeutics, Inc. 11099 North Torrey Pines Road, Ste 280 La Jolla CA CALIFORNIA 92037 Executive Officer Tighe Reardon c/o Enlaza Therapeutics, Inc. 11099 North Torrey Pines Road, Ste 280 La Jolla CA CALIFORNIA 92037 Executive Officer Jay Lichter c/o Enlaza Therapeutics, Inc. 11099 North Torrey Pines Road, Ste 280 La Jolla CA CALIFORNIA 92037 Director Shelley Chu c/o Enlaza Therapeutics, Inc. 11099 North Torrey Pines Road, Ste 280 La Jolla CA CALIFORNIA 92037 Director James Topper c/o Enlaza Therapeutics, Inc. 11099 North Torrey Pines Road, Ste 280 La Jolla CA CALIFORNIA 92037 Director Marcos Milla c/o Enlaza Therapeutics, Inc. 11099 North Torrey Pines Road, Ste 280 La Jolla CA CALIFORNIA 92037 Director Stephen Squinto c/o Enlaza Therapeutics, Inc. 11099 North Torrey Pines Road, Ste 280 La Jolla CA CALIFORNIA 92037 Director Pharmaceuticals Decline to Disclose 06b false 2025-08-29 false true false 0 15000000 15000000 0 false 1 0 0 0 false Enlaza Therapeutics, Inc. Sergio Duron Sergio Duron Chief Executive Officer 2025-09-10